Pancreatic Cancer Research

ResearcherNational and Kapodistrian University of AthensNo recent work listed

Alexios S Strimpakos

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-7293-8263; OpenAlex author ID A5026952817. Sources: OpenAlex.

Their work

Papers
11 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2011: 3 papers · 2012: 5 papers · 2013: 2 papers · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper

Papers 11

  1. Portal-mesenteric vein resection for pancreatic cancer: Results in par with the defined benchmark outcomes. Co-author DOI 10.3389/fsurg.2022.1069802↗
  2. Pharmacogenomics in pancreatic adenocarcinoma: new data and their clinical implications. Co-author DOI 10.6092/1590-8577/1662↗
  3. Update on phase I studies in advanced pancreatic adenocarcinoma. Hunting in darkness? Co-author DOI 10.6092/1590-8577/1664↗
  4. Clinical and laboratory biomarkers in the management of pancreatic adenocarcinoma. Co-author DOI 10.6092/1590-8577/943↗
  5. Novel agents and new combination treatments on phase I studies on solid tumors and pancreatic cancer. Co-author DOI 10.6092/1590-8577/947↗
  6. Clinical studies in the second line setting of advanced pancreatic cancer: are we making any progress? First author DOI 10.6092/1590-8577/948↗
  7. Novel agents in early phase clinical studies on refractory pancreatic cancer. Co-author DOI 10.6092/1590-8577/714↗
  8. Translational research. New findings and potential future applications in pancreatic adenocarcinoma. Co-author DOI 10.6092/1590-8577/712↗
  9. Translational research in pancreatic cancer. Highlights from the "2011 ASCO Gastrointestinal Cancers Symposium". San Francisco, CA, USA. January 20-22, 2011. Co-author PMID 21386635↗
  10. Biomarkers and pharmacogenetics in pancreatic cancer. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011. First author PMID 21737888↗
  11. Updates on first-line treatment of metastatic pancreatic adenocarcinoma. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011. Co-author PMID 21737891↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Muhammad Wasif Saif · 10 shared papers, 2011–2013 · strength 0.52
  2. Kostas Syrigos · 7 shared papers, 2011–2013 · strength 0.35
  3. Maria Psomas · 1 shared paper, 2022 · strength 0.15
  4. Georgia G Kostopanagiotou · 1 shared paper, 2022 · strength 0.15
  5. Gregory G. Tsiotos · 1 shared paper, 2022 · strength 0.15
  6. Vassilios Ramfidis · 1 shared paper, 2012 · strength 0.04
  7. Xunhai Xu · 1 shared paper, 2011 · strength 0.04
  8. Konstantinos Nikolaos Syrigos · 1 shared paper, 2011 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.